Whole Cell Screen for Inhibitors of pH Homeostasis in Mycobacterium tuberculosis

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Darby, Crystal M ^a   Ingólfsson, Helgi I ^a   Jiang, Xiuju ^a   Shen, Chun ^a   Sun, Mingna ^b   Zhao, Nan ^a   Burns, Kristin ^a   Liu, Gang ^b,c   Ehrt, Sabine ^a   Warren, J David ^a   Anderson, Olaf S ^a   Brickner, Steven J ^d   Nathan, Carl ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c Tsinghua University   (China)

^d SJ Brickner Consulting LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ACIDITY; ANIMAL CELL; ARTICLE; BACTERIAL SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; GENETIC SCREENING; HOMEOSTASIS; HUMAN; HUMAN CELL; IONTOPHORESIS; MICROENVIRONMENT; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PH HOMEOSTASIS; TUBERCULOSIS; WHOLE CELL;

ACID-BASE EQUILIBRIUM; ANIMALS; ANTITUBERCULAR AGENTS; CELL LINE; HIGH-THROUGHPUT SCREENING ASSAYS; HOMEOSTASIS; HUMANS; HYDROGEN-ION CONCENTRATION; MEMBRANE POTENTIALS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; VERO CELLS;

EID: 84880806669     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068942     Document Type: Article

References (33)

1. WHO (2011) Global Tuberculosis Control: WHO report 2011. Geneva.
2. Montali RJ, Mikota SK, Cheng LI, (2001) Mycobacterium tuberculosis in zoo and wildlife species. Rev Sci Tech 20: 291-303.
3. Sturgill-Koszycki S, Schlesinger PH, Chakraborty P, Haddix PL, Collins HL, et al. (1994) Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263: 678-681.
4. MacMicking JD, Taylor GA, McKinney JD, (2003) Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 302: 654-659.
5. Schaible UE, Sturgill-Koszycki S, Schlesinger PH, Russell DG, (1998) Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J Immunol 160: 1290-1296.
6. Buchmeier N, Blanc-Potard A, Ehrt S, Piddington D, Riley L, et al. (2000) A parallel intraphagosomal survival strategy shared by mycobacterium tuberculosis and Salmonella enterica. Mol Microbiol 35: 1375-1382.
7. Raynaud C, Papavinasasundaram KG, Speight RA, Springer B, Sander P, et al. (2002) The functions of OmpATb, a pore-forming protein of Mycobacterium tuberculosis. Mol Microbiol 46: 191-201.
8. Song H, Huff J, Janik K, Walter K, Keller C, et al. (2011) Expression of the ompATb operon accelerates ammonia secretion and adaptation of Mycobacterium tuberculosis to acidic environments. Mol Microbiol 80: 900-918.
9. Vandal OH, Pierini LM, Schnappinger D, Nathan CF, Ehrt S, (2008) A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis. Nat Med 14: 849-854.
10. Vandal OH, Gelb MH, Ehrt S, Nathan CF, (2006) Cytosolic phospholipase A2 enzymes are not required by mouse bone marrow derived macrophages for the control of Mycobacterium tuberculosis in vitro. Infect Immun 74: 1751-1756.
11. Vandal OH, Roberts JA, Odaira T, Schnappinger D, Nathan CF, et al. (2009) Acid-susceptible mutants of Mycobacterium tuberculosis share hypersusceptibility to cell wall and oxidative stress and to the host environment. J Bacteriol 191: 625-631.
12. Darby CM, Venugopal A, Ehrt S, Nathan CF, (2011) Mycobacterium tuberculosis gene Rv2136c is dispensable for acid resistance and virulence in mice. Tuberculosis (Edinb) 91: 343-347.
13. Small JL, O'Donoghue AJ, Boritsch EC, Tsodikov OV, Knudsen GM, et al. (2013) Substrate Specificity of MarP, a Periplasmic Protease Required for Resistance to Acid and Oxidative Stress in Mycobacterium tuberculosis. J Biol Chem 288: 12489-12499.
14. Biswas T, Small J, Vandal O, Odaira T, Deng H, et al. (2010) Structural insight into serine protease Rv3671c that Protects M. tuberculosis from oxidative and acidic stress. Structure 18: 1353-1363.
15. Miesenbock G, De Angelis DA, Rothman JE, (1998) Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature 394: 192-195.
16. Zhang Y, Yew WW, (2009) Mechanisms of drug resistance in Mycobacterium tuberculosis. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease 13: 1320-1330.
17. Ingolfsson HI, Andersen OS, (2010) Screening for small molecules' bilayer-modifying potential using a gramicidin-based fluorescence assay. Assay Drug Dev Technol 8: 427-436.
18. Ingolfsson HI, Sanford RL, Kapoor R, Andersen OS (2010) Gramicidin-based fluorescence assay; for determining small molecules potential for modifying lipid bilayer properties. J Vis Exp.
19. Berberan-Santos MN, Bodunov EN, Valeur B, (2005) Mathematical functions for the analysis of luminescence decays with underlying distributions 1. Kohlrausch decay function (stretched exponential). Chemical Physics 315: 171-182.
20. Vogt G, Nathan C, (2011) In vitro differentiation of human macrophages with enhanced antimycobacterial activity. J Clin Invest 121: 3889-3901.
21. de Carvalho LP, Darby CM, Rhee KY, Nathan C, (2011) Nitazoxanide Disrupts Membrane Potential and Intrabacterial pH Homeostasis of Mycobacterium tuberculosis. ACS Med Chem Lett 2: 849-854.
22. Lundbaek JA, Collingwood SA, Ingolfsson HI, Kapoor R, Andersen OS, (2010) Lipid bilayer regulation of membrane protein function: gramicidin channels as molecular force probes. J R Soc Interface 7: 373-395.
23. Hoult JR, Paya M, (1996) Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen Pharmacol 27: 713-722.
24. Kim JY, Su TL, Chou TC, Koehler B, Scarborough A, et al. (1996) Cyclopent[a]anthraquinones as DNA intercalating agents with covalent bond formation potential: synthesis and biological activity. J Med Chem 39: 2812-2818.
25. Kong XB, Rubin L, Chen LI, Ciszewska G, Watanabe KA, et al. (1992) Topoisomerase II-mediated DNA cleavage activity and irreversibility of cleavable complex formation induced by DNA intercalator with alkylating capability. Mol Pharmacol 41: 237-244.
26. Konig GM, Wright AD, (1999) 1H and 13C-NMR and biological activity investigations of four lichen-derived compounds. Phytochemical Analysis 10: 279-284.
27. Liu C, Xiao P, (2002) Recalling the research and development of new drugs originating from Chinese traditional and herbal drugs. Asian Journal of Drug Metabolism and Pharmacokinetics 2: 133-156.
28. Chang H, But P (1987) Pharmacology and applications of Chinese materia medica. Yao S, Wang L, Yeung S, translator. Singapore: World Scientific Publishing Co.
29. Boshoff HI, Mizrahi V, Barry CE, 3rd (2002) Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase I. J Bacteriol. 184: 2167-2172.
30. Shi W, Zhang X, Jiang X, Yuan H, Lee JS, et al. (2011) Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. Science 333: 1630-1632.
31. Zhang Y, Wade MM, Scorpio A, Zhang H, Sun Z, (2003) Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother 52: 790-795.
32. Franzblau SG, White KE, (1990) Comparative in vitro activities of 20 fluoroquinolones against Mycobacterium leprae. Antimicrob Agents Chemother 34: 229-231.
33. Mrozik A, Piotrowska-Seget Z, Labuzek S, (2004) Cytoplasmatic bacterial membrane responses to environmental perturbations. Polish Journal of Environmental Studies 13: 487-494.